Advances in neuroradiological and neurosurgical techniques have lead to a g
rowing interest in functional neurosurgical interventions for medically int
ractable movement disorders. The majority of these procedures are performed
in patients with hypokinetic movement disorders, especially Parkinson's di
sease. However, relatively few interventions were done in hyperkinetic diso
rders such as Huntington's disease (HD), mainly owing to the lack of an ade
quate target nucleus. We have recently described the case of a reversible c
horea in a genetically confirmed HD patient. We subsequently identified a m
arked bilateral degeneration of the substantia nigra as the probable reason
for choreatic cessation. We therefore suggest that primary striatal atroph
y causing hyperkinesia and secondary substantia nigra atrophy favouring hyp
okinesia were balanced in this patient, thus resulting in a close-to-physio
logic GABAergic basal ganglia output. We postulate that deep brain stimulat
ion of the substantia nigra pars compacta may ameliorate hyperkinesia in ch
oreatic, movement disorders, thus representing the first effective therapy
in Huntington's chorea. Several lines of evidence in recent neurophysiologi
cal research support our hypothesis and are discussed below. (C) 2001 Harco
urt Publishers Ltd.